Biología Molecular e Ingeniería Bioquímica
Departamento
Instituto de Biomedicina de Valencia
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Biomedicina de Valencia (11)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)
Nature
-
Erratum: Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores (Nature communications (2021) 12 1 (3417))
Nature communications
-
Genetic Associations between Modifiable Risk Factors and Alzheimer Disease
JAMA Network Open, Vol. 6, Núm. 5
2022
-
Association of Rare APOE Missense Variants V236E and R251G with Risk of Alzheimer Disease
JAMA Neurology, Vol. 79, Núm. 7, pp. 652-663
-
New insights into the genetic etiology of Alzheimer's disease and related dementias
Nature genetics, Vol. 54, Núm. 4, pp. 412-436
2021
-
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores
Nature communications, Vol. 12, Núm. 1, pp. 3417
-
Long runs of homozygosity are associated with Alzheimer’s disease
Translational Psychiatry, Vol. 11, Núm. 1
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2019
-
Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project
Alzheimer's and Dementia, Vol. 15, Núm. 10, pp. 1333-1347
2009
-
Prohibitin and mitochondrial biology
Trends in Endocrinology and Metabolism, Vol. 20, Núm. 8, pp. 394-401